Anti-HGF / Hepatocyte Growth Factor antibody

Cat.#: 101097

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-HGF / Hepatocyte Growth Factor antibody
  • Documents
  • Description
    Rabbit polyclonal to HGF / Hepatocyte Growth Factor
  • Tested applications
    ELISA, IHC-P
  • Species reactivity
    Mouse HGF / Hepatocyte Growth Factor
  • Alternative names
    sf antibody; HGF antibody; SF antibody; HGFB antibody; HPTA antibody; F-TCF antibody; DFNB39 antibody; NK1 antibody; NK2 antibody; HGF/SF antibody; SF/HGF antibody; C230052L06Rik antibody; SF antibody; HGF antibody; C230052L06Rik antibody; DFNB39 antibody; F-TCF antibody; HGF/SF antibody; HGFB antibody; HPTA antibody; NK1 antibody; NK2 antibody; SF/HGF antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with purified, recombinant Mouse HGF / Hepatocyte Growth Factor (rh HGF / Hepatocyte Growth Factor; Q08048-1; Met1-Leu728). HGF / Hepatocyte Growth Factor specific IgG was purified by Mouse HGF / Hepatocyte Growth Factor affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    ELISA:0.1-0.2 μg/mL

    This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Mouse HGF / Hepatocyte Growth Factor. The detection limit for Mouse HGF / Hepatocyte Growth Factor is < 0.039 ng/well.

    IHC-P: 0.1-1 μg/ml

  • Validations

    HGF / Hepatocyte Growth Factor Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    HGF / Hepatocyte Growth Factor Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    HGF / Hepatocyte Growth Factor Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    HGF / Hepatocyte Growth Factor Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

  • Background
    Hepatocyte growth factor, also known as HGF, contains 4 kringle domains, 1 PAN domain and 1 peptidase S1 domain. It belongs to the peptidase S1 family, plasminogen subfamily. Hepatocyte growth factor is secreted by mesenchymal cellsas a single inactive polypeptide and is cleaved by serine proteases into a 69-kDa alpha-chain and 34-kDa beta-chain. A disulfide bond between the alpha and beta chains produces the active, heterodimeric molecule. Hepatocyte growth factor regulates cell growth, cell motility, and morphogenesis by activating a tyrosine kinase signaling cascade after binding to the proto-oncogenic c-Met receptor, and acts as a multi-functional cytokine on cells of mainly epithelial origin. Its ability to stimulate mitogenesis, cell motility, and matrix invasion gives it a central role in angiogenesis, tumorogenesis, and tissue regeneration. HGF is a potent mitogen for mature parenchymal hepatocyte cells, seems to be an hepatotrophic factor, and acts as growth factor for a broad spectrum of tissues and cell types. HGF has no detectable protease activity. Defects in hepatocyte growth factor are the cause of deafness autosomal recessive type 39. A form of profound prelingual sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.
  • References
    • Naldini L, et al. (1991) Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10(10):2867-78.
    • Comoglio, et al. (1993) Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. 65:131-65.
    • Hahn W, et al. (2011) Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model. The Journal of Gene Medicine. 13(10):549-55.
    • Bottaro DP, et al. (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251(4995):802-4.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"